State of Michigan Retirement System Grows Stake in HCA Healthcare, Inc. (NYSE:HCA)

State of Michigan Retirement System grew its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,309 shares of the company’s stock after acquiring an additional 100 shares during the quarter. State of Michigan Retirement System’s holdings in HCA Healthcare were worth $18,114,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Centerpoint Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter worth about $27,000. Atlantic Edge Private Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter worth $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at about $28,000. Rise Advisors LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at approximately $36,000. Finally, Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $36,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, SVP Kathryn A. Torres sold 973 shares of the stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total transaction of $494,400.00. Following the completion of the transaction, the executive vice president now owns 34,124 shares of the company’s stock, valued at $10,544,316. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The disclosure for this sale can be found here. Insiders sold 12,397 shares of company stock worth $3,921,929 over the last ninety days. Corporate insiders own 1.70% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several research analyst reports. Robert W. Baird began coverage on HCA Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Royal Bank of Canada lifted their target price on HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Oppenheimer upped their price target on HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a report on Monday, April 29th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Finally, JPMorgan Chase & Co. increased their price target on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a report on Thursday, May 30th. Four investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $326.53.

HCA Healthcare Trading Up 1.5 %

HCA Healthcare stock opened at $319.70 on Wednesday. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $344.20. The stock has a market cap of $83.73 billion, a PE ratio of 15.94, a P/E/G ratio of 1.49 and a beta of 1.68. The stock has a 50-day moving average price of $326.06 and a 200 day moving average price of $317.80. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same quarter last year, the firm earned $4.93 earnings per share. The business’s revenue was up 11.2% on a year-over-year basis. Equities research analysts predict that HCA Healthcare, Inc. will post 20.92 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, June 28th. Investors of record on Friday, June 14th were given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.83%. The ex-dividend date was Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.